Product image of Moxostad (Moxonidine) supplied by GNH India

Moxostad

Active Ingredient:
Moxonidine
Origin:
EU

Moxostad (Moxonidine)

Moxonidine, the active ingredient in Moxostad, is an Imidazoline receptor agonist presented as a tablet for oral use. It treats hypertension by lowering blood pressure in adult patients.
GNH India supplies Moxostad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Stada Arzneimittel Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moxonidine acts on central imidazoline I1 receptors to control elevated blood pressure.

  • Essential hypertension: reduces systolic and diastolic pressure in primary hypertension.
  • Secondary hypertension: may be added to therapy when high blood pressure results from another condition.
  • Resistant hypertension: can complement existing regimens to achieve target blood pressure levels.

How It Works

  • Moxonidine selectively stimulates central imidazoline I1 receptors, which diminishes sympathetic outflow from the brainstem. This reduction in sympathetic activity leads to decreased peripheral vascular resistance and lower heart rate, ultimately producing a modest but consistent decline in arterial blood pressure.

Side Effects

Moxonidine is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Dry mouth: sensation of oral dryness without obvious cause.
  • Fatigue: feeling unusually tired or weak.
  • Dizziness: light‑headedness, especially when standing quickly.
  • Headache: mild to moderate pain in the head region.
  • Nausea: upset stomach with urge to vomit.
  • Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects

  • Severe hypotension: marked drop in blood pressure that may cause fainting.
  • Bradycardia: unusually slow heart rate.
  • Liver enzyme elevation: abnormal liver function test results.
  • Allergic reactions: rash, itching, swelling, or breathing difficulty.
  • Arrhythmia: irregular heart rhythm.
  • Depression: mood changes or depressive symptoms.

Precautions & Warnings

Before initiating therapy, certain safety considerations are recommended.

  • Monitor blood pressure: check regularly to avoid excessive hypotension.
  • Assess renal function: adjust dose if kidney impairment is present.
  • Avoid abrupt discontinuation: sudden stop may trigger rebound hypertension.
  • Caution in elderly: increased sensitivity to blood‑pressure lowering effects.
  • Store at room temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Moxonidine can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

  • Combined with other antihypertensives (e.g., ACE inhibitors, beta‑blockers) may cause excessive hypotension.
  • Concomitant use with central sympatholytics (e.g., clonidine) increases risk of severe blood‑pressure drop.
  • Potassium‑sparing diuretics may potentiate hypotensive effect.
  • Strong CYP2D6 inhibitors may raise plasma concentrations of moxonidine.
  • Alcohol: additive sedative and hypotensive effects.

Moderate Interactions (Monitor Closely)

  • NSAIDs may reduce antihypertensive efficacy.
  • Loop or thiazide diuretics may alter electrolyte balance.
  • Lithium levels can increase, requiring monitoring.
  • Tricyclic antidepressants may enhance hypotensive response.

Frequently Asked Questions

Moxostad contains the active ingredient moxonidine, which is prescribed to lower high blood pressure in adults. It belongs to the class of imidazoline receptor agonists and is used primarily for the management of essential, secondary, or resistant hypertension.

Moxonidine selectively activates central imidazoline I1 receptors in the brainstem, reducing sympathetic nervous system activity. This leads to decreased peripheral vascular resistance and a modest reduction in heart rate, together producing a lowering of arterial blood pressure.

The dosage of Moxostad is individualized by the prescribing clinician based on the patient’s blood‑pressure readings, overall health, and response to therapy. The prescriber determines the appropriate strength, frequency, and duration of treatment.

Safety data for moxonidine in pregnancy and lactation are limited, and the product’s pregnancy category is not established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified health professional.

To request Moxostad, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Moxostad (moxonidine) differs from many antihypertensives by targeting central imidazoline I1 receptors rather than angiotensin‑converting enzyme, calcium channels, or beta‑adrenergic pathways. This mechanism can provide modest blood‑pressure reduction with a distinct side‑effect profile, making it useful as an add‑on therapy when other classes are insufficient.

Moxostad tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Moxostad is taken orally, usually with or without food, as directed by the prescribing physician. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious risks include severe hypotension, bradycardia, significant liver enzyme elevation, and rare allergic reactions such as rash, swelling, or breathing difficulty. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, or signs of an allergic response.

Moxostad is contraindicated in patients with known hypersensitivity to moxonidine or any excipients, and it should be used with caution in individuals with severe renal impairment, uncontrolled heart failure, or those taking other central sympatholytic agents that could cause excessive blood‑pressure lowering.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxonidine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT